A trial looking at preventing bowel cancer with aspirin or resistant starch (CAPP 2)
This trial looked at aspirin and starch to prevent people with a rare condition called HNPCC from developing bowel cancer.
Cancer of the large bowel. Waste left from digested food passes from the small bowel to the colon, where fluid and foods are absorbed. The waste then goes through to the rectum (back passage) and then through the anus to be passed out of the body. Also called the large intestine or the bowel.
This trial looked at aspirin and starch to prevent people with a rare condition called HNPCC from developing bowel cancer.
This trial looked at a new chemotherapy drug called patupilone for people with bowel cancer (colorectal cancer) that had spread.
This trial looked at the genetic material (DNA) of people who had chemotherapy for advanced bowel cancer.
This trial compared capecitabine and bevacizumab with capecitabine alone for bowel (colorectal) cancer.
The aim of this study was to find the best way to follow up patients after treatment for bowel cancer.
This study looked to see if certain indicators (biomarkers) of cancer risk change after weight loss.
This study compared MRI scans and CT scans in bowel cancer to see which was more accurate in helping doctors see how far a cancer had spread.
This study is looking at a fish oil supplement called eicosapentaenoic acid or EPA.
This study was done to find out more about how people recover from surgery for bowel cancer.
This trial looked at whether vitamin B6 (pyridoxine) tablets could help relieve hand foot syndrome caused by the chemotherapy drug capecitabine.